Skip to content

Review-State-Aware Comparison

Amazonian Guaraná vs Borage

An automated side-by-side view of two public profiles. It has not been individually curated as a clinical comparison and is excluded from search indexing. Scores and narratives are provisional unless a profile explicitly states human approval; no personal dosage or combination conclusion is provided.

This page cannot establish which ingredient is better, whether either is effective, or whether they can be combined safely. Editorial and quality-gate review approved this evidence record. Editorial and quality-gate review approved this evidence record.

Amazonian Guaraná

Amazonian Guaraná

Seed · Compound
Human-reviewed public score: 10/10
VS
Borage

Borage

Herb · Compound
Human-reviewed public score: 10/10
Amazonian Guaraná
Borage
Category
Seed
Herb
Public Score
10/10 (validated)
10/10 (validated)
Screened PMIDs
—
—
Entity Type
Compound
Compound
Overview
Amazonian guaraná (Paullinia cupana) delivers sustained cognitive and metabolic benefits primarily through its methylxanthines—caffeine (guaranine), theobromine, and theophylline—which antagonize adenosine A1 and A2A receptors to enhance alertness, while its catechin and epicatechin flavonoids activate the Nrf2 transcription pathway to upregulate endogenous antioxidant defenses. A comprehensive safety review published in the Journal of Agricultural and Food Chemistry (PMID 31539257) confirmed guaraná seed's well-established dietary safety profile, and laboratory research demonstrated that guaraná extract modulates oxidative metabolism and promotes cellular repair in fibroblast wound-healing models (PMID 35795860).
Borage (Borago officinalis) delivers potent anti-inflammatory and skin-barrier repair effects primarily through its gamma-linolenic acid (GLA), which converts to DGLA to suppress TNF-alpha via increased cAMP signaling—a mechanism demonstrated to reduce rheumatoid arthritis activity (PMID 11710548). Its phenolic compounds, including rosmarinic acid, quercetin, and kaempferol, synergistically inhibit pro-inflammatory prostaglandin and leukotriene synthesis, while topical borage oil has been shown to restore epidermal barrier function and reduce transepidermal water loss in dermatological studies (PMID 29280987).
Dosage
Withheld: no dosage-supported approval.
Withheld: no dosage-supported approval.

Human-Reviewed Benefit Text

Amazonian Guaraná

Provides sustained energy and mental clarity through guaranine and theobromine, promoting prolonged focus and alertness
Enhances cognitive function and neuroprotection by supporting neurotransmitter activity and brain resilience against oxidative stress
Activates metabolic processes and fat burning by stimulating thermogenesis and calorie expenditure
Supports cardiovascular and circulatory health with flavonoids that improve endothelial function and regulate blood pressure
Offers potent antioxidant and cellular protection through catechins and polyphenols that neutralize free radicals
Promotes gut and digestive health via tannins that enhance digestive efficiency and support a balanced microbiome

Borage

Supports skin health by reducing inflammation and promoting hydration, particularly beneficial for conditions like eczema, due to its GLA content
Enhances hormonal balance, especially in managing symptoms of PMS and menopause, by modulating prostaglandin synthesis
Provides significant anti-inflammatory effects through its gamma-linolenic acid (GLA), alleviating symptoms of inflammatory conditions
Boosts cardiovascular health by potentially reducing blood pressure and improving circulation, though more research is needed
Promotes mental well-being by reducing stress and anxiety, possibly through its calming effects on the nervous system

Human-Reviewed Mechanism Text

Amazonian Guaraná

Guaraná's primary bioactive methylxanthines—caffeine (2–5% dry weight), theobromine, and theophylline—competitively antagonize adenosine A1 and A2A receptors in the central nervous system, thereby blocking adenosine's inhibitory signaling, increasing synaptic dopamine and norepinephrine release, and enhancing alertness, reaction time, and sustained attention. Its proanthocyanidins, catechins, and epicatechins scavenge reactive oxygen species (ROS) through electron donation from multiple hydroxyl groups and simultaneously activate the Keap1-Nrf2-ARE signaling axis, promoting transcription of phase II antioxidant enzymes including superoxide dismutase (SOD), glutathione peroxidase (GPx), and heme oxygenase-1 (HO-1). Guaraná's tannins and saponins further modulate NF-κB-mediated inflammatory cascades, reducing pro-inflammatory cytokines such as TNF-α and IL-6, which contributes to its documented anti-inflammatory and anti-apoptotic effects in dermal fibroblasts (PMID 31343815). Additionally, caffeine-mediated phosphodiesterase inhibition elevates intracellular cyclic AMP (cAMP), stimulating lipolysis and thermogenesis in adipose tissue, underpinning guaraná's metabolic activation properties.

Borage

Borage seed oil contains 20–26% gamma-linolenic acid (GLA), which is enzymatically converted by elongase to dihomo-gamma-linolenic acid (DGLA); DGLA competitively inhibits the cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) conversion of arachidonic acid into pro-inflammatory prostaglandin E2 (PGE2) and leukotriene B4 (LTB4). DGLA also serves as a precursor for the anti-inflammatory prostaglandin E1 (PGE1), which elevates intracellular cyclic adenosine monophosphate (cAMP), thereby suppressing tumor necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) release from macrophages and T-cells (PMID 11710548). The herb's polyphenolic fraction—rich in rosmarinic acid, quercetin, and kaempferol—further inhibits NF-κB nuclear translocation and downregulates inducible nitric oxide synthase (iNOS) and COX-2 gene expression (PMID 27247570). Topically, borage oil's linoleic acid and GLA integrate into lamellar lipid bilayers in the stratum corneum, restoring ceramide synthesis and reducing transepidermal water loss (PMID 29280987).

Human-Reviewed Safety Text

Amazonian Guaraná:

A comprehensive safety review by Patrick et al. (2019, PMID 31539257) confirmed that guaraná seed is generally recognized as safe (GRAS) when consumed at standard dietary doses (typically 75–200 mg/day caffeine equivalent), with adverse effects primarily dose-dependent and consistent with excess caffeine intake—including insomnia, tachycardia, anxiety, and gastrointestinal distress. Guaraná's caffeine is a substrate and inhibitor of cytochrome P450 1A2 (CYP1A2), and concurrent use with CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin) or substrates (e.g., theophylline, clozapine) may increase plasma caffeine levels and potentiate adverse effects. Guaraná should be used cautiously alongside anticoagulants (warfarin), MAO inhibitors, stimulant medications, and ephedra-containing products due to additive cardiovascular stimulation; it is contraindicated in individuals with uncontrolled hypertension, cardiac arrhythmias, or caffeine hypersensitivity. Pregnant and lactating women are advised to limit guaraná consumption consistent with general caffeine guidelines (≤200 mg caffeine/day per WHO recommendations).

Borage:

Unrefined borage plant parts contain unsaturated pyrrolizidine alkaloids (UPAs) such as amabiline and lycopsamine, which are hepatotoxic and potentially carcinogenic; only certified PA-free borage seed oil should be consumed orally (PMID 32105669; PMID 30000849). Borage oil may potentiate anticoagulant and antiplatelet drugs (e.g., warfarin, aspirin) due to GLA's effect on thromboxane A2 inhibition, increasing bleeding risk, and should be discontinued at least two weeks before surgery. Individuals taking hepatotoxic medications, anticonvulsants (which may lower seizure threshold due to GLA's prostaglandin effects), or NSAIDs should consult a healthcare provider before use. No significant CYP450 interactions have been conclusively documented, but caution is advised with CYP3A4 substrates given preliminary in-vitro data on polyphenol-mediated enzyme modulation.

Comparison summary

This automated view does not establish that either Amazonian Guaraná or Borage is effective, superior, suitable, or safe to combine. Both have the same provisional public score (10/10). This ordering does not establish clinical superiority, safety, or suitability. Use the linked profiles and a qualified healthcare professional for decisions.

Frequently Asked Questions

Is Amazonian Guaraná or Borage better?

Amazonian Guaraná and Borage have the same provisional public score (10/10). A score tie does not establish equivalent evidence or outcomes.

Can you take Amazonian Guaraná and Borage together?

No reviewed combination conclusion is established by this comparison. A missing reviewed interaction record means unknown, not safe. Consult a qualified healthcare professional before combining supplements.

What is the main difference between Amazonian Guaraná and Borage?

Amazonian Guaraná is categorized as seed (Compound), while Borage is categorized as herb (Compound). Category labels are classification fields, not evidence of benefit; claim-bearing text appears only when both profiles have recorded human approval.

Read Full Amazonian Guaraná Monograph →Read Full Borage Monograph →

These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.